ArticleBMJ (Clinical research ed.)2001
Prescribing new drugs: qualitative study of influences on consultants and general practitioners.
Article in BMJ (Clinical research ed.), 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 175 citations in OpenAlex.
- Factors Affecting Prescriber Implementation of Computer-Generated Medication Recommendations in the SENATOR Trial: A Qualitative Study.Drugs & aging · 2020Trial
- Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis.BMC public health · 2013Trial
- [Efficacy of educational sessions to modify the prescription of new drugs].Atencion primaria · 2005Trial
- Importance of patient pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study.BMJ (Clinical research ed.) · 2004Trial
- Pharmaceutical company promotional payments to English general practices: a longitudinal study.BJGP open · 2026Article
- Association between patient continuity of care and physicians' hypoglycaemic medication prescription trends.International journal of health economics and management · 2026Article
- Marketing of medicines in primary care: An analysis of direct marketing mailings and advertisements.PloS one · 2023Article
- Real-World Use of Molnupiravir in the Treatment of Outpatients with SARS-CoV-2 Infection-A Patient Profile Based on the Experience of a Tertiary Infectious Disease Center.Pharmaceuticals (Basel, Switzerland) · 2022Article
- The attitude and acceptability towards medical promotional tools and their influence on physicians' prescribing practices in Jordan and Iraq: a cross-sectional study.BMC health services research · 2022Article
- Impact of a change of bronchodilator medications in a hospital drug formulary on intra- and out-of-hospital drug prescriptions: interrupted time series design with comparison group.Implementation science : IS · 2020Article
- Usability and feasibility of consumer-facing technology to reduce unsafe medication use by older adults.Research in social & administrative pharmacy : RSAP · 2020Article
- Variation in responsiveness to warranted behaviour change among NHS clinicians: novel implementation of change detection methods in longitudinal prescribing data.BMJ (Clinical research ed.) · 2019Article
- Article
- Seeding trials: Marketing gimmick or credible scientific research.Indian journal of anaesthesia · 2019Article
- Article
- Factors Influencing Prescribing Perceived Utility of Drugs: Experiences from Iraqi Kurdistan.Innovations in pharmacy · 2019Article
- The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians.CMAJ open · 2018Article
- Early National Dissemination of Abiraterone and Enzalutamide for Advanced Prostate Cancer in Medicare Part D.Journal of oncology practice · 2017Article
- Using qualitative research methods in biomedical innovation: the case of cultured red blood cells for transfusion.BMC research notes · 2016Article
- Prescribing and practice development decision-making in Irish general practices.Irish journal of medical science · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore consultants' and general practitioners' perceptions of the factors that influence their decisions to introduce new drugs into their clinical practice.
designQualitative study using semistructured interviews. Monitoring of hospital and general practice prescribing data for eight new drugs.
settingTeaching hospital and nearby general hospital plus general practices in Birmingham.
participants38 consultants and 56 general practitioners who regularly referred to the teaching hospital.
main outcome measuresReasons for prescribing a new drug; sources of information used for new drugs; extent of contact between consultants and general practitioners; and amount of study drugs used in hospitals and by general practitioners.
resultsConsultants usually prescribed new drugs only in their specialty, used few new drugs, and used scientific evidence to inform their decisions. General practitioners generally prescribed more new drugs and for a wider range of conditions, but their approach varied considerably both between general practitioners and between drugs for the same general practitioner. Drug company representatives were an important source of information for general practitioners. Prescribing data were consistent with statements made by respondents.
conclusionsThe factors influencing the introduction of new drugs, particularly in primary care, are more multiple and complex than suggested by early theories of drug innovation. Early experience of using a new drug seems to strongly influence future use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.